N-/T-Type vs. L-Type Calcium Channel Blocker in Treating Chronic Kidney Disease: A Systematic Review and Meta-Analysis

• Үндсэн зохиолчид: Mingming Zhao (Зохиогч), Ziyan Zhang (Зохиогч), Zhiyu Pan (Зохиогч), Sijia Ma (Зохиогч), Meiying Chang (Зохиогч), Jiao Fan (Зохиогч), Shunxuan Xue (Зохиогч), Yuejun Wang (Зохиогч), Hua Qu (Зохиогч), Yu Zhang (Зохиогч)
• Формат: Ном
• Хэвлэсэн: MDPI AG, 2023-02-01T00:00:00Z.
• Нөхцлүүд: article
• Онлайн хандалт: Connect to this object online.

Renin-angiotensin system (RAS) inhibitors and calcium channel blockers (CCB) are often used together in chronic kidney disease (CKD). The PubMed, EMBASE, and Cochrane Library databases were searched to identify randomized controlled trials (RCTs) in order to explore better subtypes of CCB for the tr...